CMS Open Payments · Program Year 2024
Ethicon US, LLC
Ethicon US, LLC reported $1,601,006.84 across General Payments, Research, and Ownership to 15,448 physicians and teaching hospitals across 15,448 transactions.
- $1.6M Above-median payer
- All-tracks total
- 15,448 Top 10% volume
- Transactions
- 15,448 Top 10% reach
- Recipients
- +$529.6K
- General Payments vs PY2023
Ethicon US, LLC reported $1,601,006.84 across all CMS Open Payments tracks (General + Research + Ownership) to 15,448 physicians and teaching hospitals in Program Year 2024 - ranking #507 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,601,006.84, averaging $103.64 per recipient.
Ethicon US, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
C
76/100
Total payments
F
25/100
Transaction volume
A
100/100
Physician reach
A
100/100
Payment type diversity
C
77/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer ethicon-us-llc Ethicon US, LLC
$1.6M · #507/1,925 · 0.0% industry · PY2024
- TOT $1.6M
- RANK #507
- SHARE 0.0%
- TXN 15,448
- RCP 15,448
- CAT 6
- GEN $1.6M
- ΔGEN +$529.6K
- TOP1 2.2%
- PY 2024
Volume peers
Nearest volume peer: Grifols Shared Services North America, Inc. ($1.6M)
Ethicon US, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Ethicon US, LLC's CMS-reported General Payments increased by $529.6K (+49.4%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ETHICON US, LLCPY2023: ETHICON US, LLCPY2024: Ethicon US, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,071,402.72
- PY2024
- $1,601,006.84
What the Data Shows for Ethicon US, LLC
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Ethicon US, LLC that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
"Consulting Fee" leads the 6-category general-payment breakdown below at $921.1K (57.5% of General Payments, 212 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Across 6 types of general payments, Ethicon US, LLC's largest category was "Consulting Fee" at $921.1K - 57.5% of General Payments.
Ethicon US, LLC reports 6 general-payment categories - the top three are Consulting Fee (57.5%), Food and Beverage (38.2%), and Space Rental or Facility Fees (2.9%). The remaining 3 categories make up 1.3% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Ethicon US, LLC divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $921.1K | 212 | 57.5% |
| Food and Beverage | $612.3K | 15,105 | 38.2% |
| Space Rental or Facility Fees | $47.1K | 14 | 2.9% |
| Travel and Lodging | $13.4K | 86 | 0.8% |
| Grant | $4.6K | 1 | 0.3% |
| Education | $2.4K | 30 | 0.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $129,634.26 (8.1%) of $1,601,006.84 in this company's General Payments records across 10,163 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Ethicon US, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Peter Dipasco
$35,613.22 across 7 reported transactions
- 2
Arthur T Martella
$30,407.00 across 4 reported transactions
- 3
John Ledonne
$22,865.33 across 18 reported transactions
- 4
Kulmeet K Sandhu
$21,957.24 across 4 reported transactions
- 5
Robert F Short
$18,791.47 across 9 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Ethicon US, LLC ranks #507 of 1,925 by total payments (top 26% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,781 of 1,838 by HHI (bottom 3% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Greer Laboratories, Inc. : $9.8K total payments, HHI 43
- Benco Dental Supply Co. : $148.4K total payments, HHI 43
- Premier Dental Products Company : $182.7K total payments, HHI 43
- DePuy Synthes Sales Inc. : $2.4M total payments, HHI 42
- IBSA Pharma Inc. : $247.0K total payments, HHI 42
- Supernus Pharmaceuticals, Inc. : $4.4M total payments, HHI 42
- Ethicon US, LLC (this company) : $1.6M total payments, HHI 41
- Pylant Medical : $104.7K total payments, HHI 40
- Teva Pharmaceuticals USA, Inc. : $13.9M total payments, HHI 40
- American Orthodontics Corporation : $374.7K total payments, HHI 38
- Impel Pharmaceuticals LLC : $15.8K total payments, HHI 36
- Ultradent Products Inc : $1.8M total payments, HHI 36
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Ethicon US, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Ethicon US, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Ethicon US, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
restor3d, inc.
Avita Medical Americas, Llc
Datascope Corp.
Valneva Austria GMBH
Rigel Pharmaceuticals, Inc.
Put this to use
Ethicon US, LLC ranks #507 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Ethicon US, LLC sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Ethicon US, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.